Rubella susceptibility among pregnant women in North London, 1996-1999

Journal of Public Health Medicine

Volumn 24, Issue 3, 2002, Pages 211-216

  Tookey, Pat A ^a   Cortina Borja, Mario ^a   Peckham, Catherine S ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Inequality; Pregnancy; Routine data; Rubella

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ADULT; ARTICLE; ASIAN; CONGENITAL RUBELLA SYNDROME; ETHNIC GROUP; FEMALE; HIGH RISK POPULATION; HUMAN; INFECTION RISK; INFECTION SENSITIVITY; NEGRO; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR; RUBELLA; UNITED KINGDOM; VACCINATION; COMPARATIVE STUDY; DISEASE PREDISPOSITION; ETHNOLOGY; IMMUNOLOGY; MIGRATION; PREVENTIVE HEALTH SERVICE; STATISTICAL MODEL;

ADULT; DISEASE SUSCEPTIBILITY; EMIGRATION AND IMMIGRATION; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; LOGISTIC MODELS; LONDON; PREGNANCY; RUBELLA;

EID: 0036739328     PISSN: 09574832     EISSN: None     Source Type: Journal    
DOI: 10.1093/pubmed/24.3.211     Document Type: Article

References (13)

1. Tookey PA, Peckham CS. Surveillance of congenital rubella in Great Britain, 1976-96. Br Med J 1999; 318: 769-770.
2. Sheridan E, Aitken C, Jeffries D, Hird M, Thayalasekaran P. Congenital rubella syndrome: a risk in immigrant populations. Lancet 2002; 359: 674-675.
3. Tookey P. Congenital rubella - down but not out (letter). Lancet 2002; in press.
4. Miller E, Waight P, Gay N, et al. The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign, fourth report from the PHLS and the National Congenital Rubella Surveillance Programme. Commun Dis Rep CDR Rev 1997; 7: R26-R32.
5. Thompson NP, Montgomery SM, Pounder RE, Wakefield AJ. Is measles vaccination a risk factor for inflammatory bowel disease? Lancet 1995; 345: 1071-1074.
6. Wakefield AJ, Murch SH, Anthony A, et al. Ileal-lymphoid nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998; 351: 1327-1328.
7. National Statistics and Department of Health. NHS immunisation statistics, England: 2000-01. Statistical Bulletin 2001/21. [On-line.] http://www.doh.gov.uk/public/sb0121/ (23 April 2002, date last accessed).
8. PHLS. COVER programme: October to December 2001. Vaccination coverage statistics for children up to five years of age in the United Kingdom. Commun Dis Rep CDR Wkly 2002; 12(13): immunisation. [On-line.] http://www.phls.co.uk/publications/CDR %20Weekly/pages/immunisation.html (23 April 2002, date last accessed).
9. Peltola H, Patja A, Leinikki P, et al. No evidence for measles, mumps and rubella vaccine associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet 1998; 351: 1327-1328.
10. Taylor B, Miller E, Farrington CP, et al. Autism and measles, mumps and rubella vaccine: no epidemiological evidence for a causal association. Lancet 1999; 353: 2026-2029.
11. Elliman D, Bedford H. MMR vaccine: the continuing saga. Br Med J 2001; 322: 183-184.
12. Medicines Control Agency, Department of Health. Combined measles, mumps and rubella vaccines: response of the Medicines Control Agency and Department of Health to issues raised in papers published in 'Adverse Drug Reactions and Toxicological Reviews, volume 19, no. 4, 2000'. [On-line.] http://www.doh.gov.uk/mmrresponse.htm (3 May 2002, date last accessed).
13. Davidkin I, Peltola H, Leinikki P, Valle M. Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland. Vaccine 2000; 18: 3106-3112.